Cargando…

Controversies in the use & implementation of drug-eluting stent technology

The introduction of drug eluting stents has resulted in dramatic reductions in the rates of restenosis and the need for repeat revascularization. In the last several years, concern has been raised regarding the long-term safety of this technology, particularly in the area of late restenosis and sten...

Descripción completa

Detalles Bibliográficos
Autores principales: Itagaki, Brandon K., Brar, Somjot S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612322/
https://www.ncbi.nlm.nih.gov/pubmed/23391788
_version_ 1782264647921958912
author Itagaki, Brandon K.
Brar, Somjot S.
author_facet Itagaki, Brandon K.
Brar, Somjot S.
author_sort Itagaki, Brandon K.
collection PubMed
description The introduction of drug eluting stents has resulted in dramatic reductions in the rates of restenosis and the need for repeat revascularization. In the last several years, concern has been raised regarding the long-term safety of this technology, particularly in the area of late restenosis and stent thrombosis. The development of newer anti-restenotic drug coatings, biodegradable polymers and even completely bioabsorbable stents offer the potential to address these limitations. Additional questions that have recently come to the forefront include the optimal duration of dual antiplatelet therapy, the use of platelet reactivity assays and genetic testing and drug eluting stent use in the treatment of acute myocardial infarction. This article will attempt to address these and other areas of controversy in the use and implementation of drug eluting stents.
format Online
Article
Text
id pubmed-3612322
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-36123222013-04-24 Controversies in the use & implementation of drug-eluting stent technology Itagaki, Brandon K. Brar, Somjot S. Indian J Med Res Review Article The introduction of drug eluting stents has resulted in dramatic reductions in the rates of restenosis and the need for repeat revascularization. In the last several years, concern has been raised regarding the long-term safety of this technology, particularly in the area of late restenosis and stent thrombosis. The development of newer anti-restenotic drug coatings, biodegradable polymers and even completely bioabsorbable stents offer the potential to address these limitations. Additional questions that have recently come to the forefront include the optimal duration of dual antiplatelet therapy, the use of platelet reactivity assays and genetic testing and drug eluting stent use in the treatment of acute myocardial infarction. This article will attempt to address these and other areas of controversy in the use and implementation of drug eluting stents. Medknow Publications & Media Pvt Ltd 2012-12 /pmc/articles/PMC3612322/ /pubmed/23391788 Text en Copyright: © The Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Itagaki, Brandon K.
Brar, Somjot S.
Controversies in the use & implementation of drug-eluting stent technology
title Controversies in the use & implementation of drug-eluting stent technology
title_full Controversies in the use & implementation of drug-eluting stent technology
title_fullStr Controversies in the use & implementation of drug-eluting stent technology
title_full_unstemmed Controversies in the use & implementation of drug-eluting stent technology
title_short Controversies in the use & implementation of drug-eluting stent technology
title_sort controversies in the use & implementation of drug-eluting stent technology
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612322/
https://www.ncbi.nlm.nih.gov/pubmed/23391788
work_keys_str_mv AT itagakibrandonk controversiesintheuseimplementationofdrugelutingstenttechnology
AT brarsomjots controversiesintheuseimplementationofdrugelutingstenttechnology